RE:RE:RE:RE:Opportunity Knocking!!!End of Q3 positioning of Funds might have something to do with this week's trading.
Until management can demonstrate bottom line performance in their core business, investor confidence is parked. Bottom line performance in their core business has been negative since 2019. Turn that around and the share price trend will turn around.
There have been many barriers to Viemed's performance and it does not look like those barriers wil evaporate overnight. Viemed must find ways to overcome those barriers for their business model to be successful. Patient uploads in July were up by 3% over June. Reported to be the highest level since the pandemic started. It would be nice to see 5% increase in patient uploads in Q3 over Q2. That will help pay for staff hirings and hopefully add to the bottom line.